Tirzepatide has emerged as a potential new option for individuals with type 2 diabetes. This groundbreaking medication combines the actions of two agents, GLP-1 and GIP, to effectively reduce blood sugar levels. Early https://socialaffluent.com/story6047795/is-tirzepatide-the-future-of-diabetes-management